Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 6:3:125.
doi: 10.1186/2193-1801-3-125. eCollection 2014.

Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method

Amalia Plotogea  1 , Anna M Chiarelli  1 , Lucia Mirea  2 , Maegan V Prummel  3 , Nelson Chong  3 , Rene S Shumak  3 , Frances P O'Malley  4 , Claire Mb Holloway  5 ; Breast Screening Study Group
Affiliations

Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method

Amalia Plotogea et al. Springerplus. .

Abstract

Introduction: Although prognostic differences between screen-detected, interval and symptomatic breast cancers are known, factors associated with wait times to diagnosis among these three groups have not been studied.

Methods: Of the 16,373 invasive breast cancers diagnosed between January 1, 1995 and December 31, 2003 in a cohort of Ontario women aged 50 to 69, a random sample (N = 2,615) were selected for chart abstraction. Eligible women were classified according to detection method; screen-detected (n = 1181), interval (n = 319) or symptomatic (n = 406). Diagnostic wait time was calculated from the initial imaging or biopsy to breast cancer diagnosis. Logistic regression analysis examined associations between diagnostic wait times dichotomized as greater or less than the median and demographic, clinical and prognostic factors separately for each detection cohort.

Results: Women who underwent an open biopsy had significantly longer than median wait times to diagnosis, compared to women who underwent a fine needle aspiration or core biopsy; (screen-detected OR = 2.76, 95% CI = 2.14-3.56; interval OR = 2.56, 95% CI = 1.50-4.35; symptomatic OR = 5.56, 95% CI = 3.33-9.30). Additionally, screen-detected breast cancers diagnosed with stage II and symptomatic cancers diagnosed at stage III or IV had significantly shorter diagnostic wait times compared to those diagnosed at stage 1 (OR = 0.66 95% CI = 0.50-0.87 and OR = 0.46, 95% CI = 0.25-0.85 respectively).

Conclusions: Our study is consistent with expedited diagnostic work-up for breast cancers with more advanced prognostic features. Furthermore, women who had an open surgical biopsy had a greater than the median diagnostic wait time, irrespective of detection method.

Keywords: Breast cancer; Diagnostic wait time; Interval cancers; Mammography; Screen-detected cancers; Symptomatic cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study population leading to final cohort with median delay for the 3 detection cohorts.
See this image and copyright information in PMC

References

    1. Cancer staging manual. 6. New York, NY: Springer-Verlag; 2002.
    1. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T, National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009;7(10):1060–1096. - PubMed
    1. Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. 2010;116(17):4160–4167. doi: 10.1002/cncr.25427. - DOI - PubMed
    1. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med. 1998;20(4):396–403. doi: 10.1093/oxfordjournals.pubmed.a024793. - DOI - PubMed
    1. Burgess CC, Ramirez AJ, Richards MA, Love SB. Who and what influences delayed presentation in breast cancer? Br J Cancer. 1998;77(8):1343–1348. doi: 10.1038/bjc.1998.224. - DOI - PMC - PubMed

LinkOut - more resources